ARCHIVES

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

Clearinghouse Subgroup asks For Tests On Three Chemicals

October 7, 1977

PDF file includes 8-page February issue of Business & Regulatory Report.

February 27, 2004

ACS Approves New Workplaces Intervention Cancer Control Program

April 17, 1992

DCC Board Approves Concept for Computer System To Reduce Dependence On NIH

June 1, 1990

Cancer Research Faces A “Strategic Inflection,” NCI Director Says

April 19, 2002

In Brief: Kalt Named Director, NCI extramural Div.; Browning Is Deputy; Other DEA Staff Changes

June 10, 1994